<VariationArchive VariationID="660681" VariationName="NC_000023.11:g.(?_37780009)_(37783620_?)del" VariationType="Deletion" Accession="VCV000660681" Version="10" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2019-08-14" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="653677" VariationID="660681">
      <GeneList>
        <Gene Symbol="CYBB" FullName="cytochrome b-245 beta chain" GeneID="1536" HGNC_ID="HGNC:2578" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp21.1-11.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37780059" stop="37813461" display_start="37780059" display_stop="37813461" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="37639269" stop="37672713" display_start="37639269" display_stop="37672713" Strand="+" />
          </Location>
          <OMIM>300481</OMIM>
          <Haploinsufficiency last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYBB">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-05-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=CYBB">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC130068093" FullName="ATAC-STARR-seq lymphoblastoid active region 29519" GeneID="130068093" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>Xp21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="37780101" stop="37780150" display_start="37780101" display_stop="37780150" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.(?_37780009)_(37783620_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" innerStart="37780009" innerStop="37783620" display_start="37780009" display_stop="37783620" variantLength="3612" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="37639262" innerStop="37642873" display_start="37639262" display_stop="37642873" variantLength="3612" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(?_37780009)_(37783620_?)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(?_37780009)_(37783620_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_37639262)_(37642873_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_37639262)_(37642873_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.(?_37780009)_(37783620_?)del AND Granulomatous disease, chronic, X-linked" Accession="RCV000817933" Version="8">
        <ClassifiedConditionList TraitSetID="3042">
          <ClassifiedCondition DB="MedGen" ID="C1844376">Granulomatous disease, chronic, X-linked</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-07-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-07-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-08-14" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20729109</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9454688</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9585602</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3042" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1398" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Granulomatous disease, chronic, X-linked</ElementValue>
                <XRef ID="MONDO:0010600" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRANULOMATOUS DISEASE, CHRONIC, X-LINKED, SOMATIC MOSAIC</ElementValue>
                <XRef Type="Allelic variant" ID="300481.0021" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYTOCHROME b-NEGATIVE GRANULOMATOUS DISEASE, CHRONIC, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CGDX</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">X-CGD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CGD</ElementValue>
                <XRef Type="MIM" ID="306400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils) resulting from impaired killing of bacteria and fungi. CGD is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory responses resulting in granuloma formation and other inflammatory disorders such as colitis. Infections typically involve the lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis). Granulomas typically involve the genitourinary system (bladder) and gastrointestinal tract (often the pylorus initially, and later the esophagus, jejunum, ileum, cecum, rectum, and perirectal area). Some males with X-linked CGD have McLeod neuroacanthocytosis syndrome as the result of a contiguous gene deletion. While CGD may present anytime from infancy to late adulthood, the vast majority of affected individuals are diagnosed before age five years. Use of antimicrobial prophylaxis and therapy has greatly improved overall survival.</Attribute>
                <XRef ID="NBK99496" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15294" />
                <XRef ID="15294" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876374</ID>
                <ID Source="BookShelf">NBK99496</ID>
              </Citation>
              <XRef ID="379" DB="Orphanet" />
              <XRef ID="C1844376" DB="MedGen" />
              <XRef ID="MONDO:0010600" DB="MONDO" />
              <XRef Type="MIM" ID="306400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1852789" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="NM_000397.3_X_Deletion (exons 1-3)|MedGen:C1844376" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000958520" DateUpdated="2024-06-09" DateCreated="2019-08-14" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9585602</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20729109</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9454688</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 1-3 of the CYBB gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 3 of the CYBB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CYBB are known to be pathogenic (PMID: 9585602, 20729109). A deletion of exons 1-3 has been observed in an individual affected with X-linked chronic granulomatous disease (PMID: 9454688). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_37639262)_(37642873_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1844376" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB5371970</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1852789" TraitType="Disease" MappingType="XRef" MappingValue="C1844376" MappingRef="MedGen">
        <MedGen CUI="C1844376" Name="Granulomatous disease, chronic, X-linked" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

